Neuroscience technology
Our intelligence.
Our Evolution
Cerebro exists to advance human intelligence through a deeper understanding of the brain.
Our mission
Understand the brain.
Advance human intelligence.
We are advancing our understanding of the human brain to extend our capacity to learn, reason, create, and discover. Our objective is human superintelligence.
That work begins with measuring how our brains function, adapt, and change—and studying how interconnected systems give rise to our capabilities. We aim to turn that understanding into ways to preserve, restore, and enhance them.
The signals we study
Understanding begins
with measurement.
Five domains offer different ways to observe brain function. Explore how each contributes to the picture.
See how we study them togetherHow the eyes move, find a target, and sustain visual attention. Example: Following a moving target.
Illustrative examples · not a test or patient data01 / Approach
One signal is a fragment.
Study the relationships.
Challenge the system. Measure the responses. Analyze how the signals behave together.
Introduce a stimulus.
A structured task asks the system to respond.
The science behind the sequence
Dynamic Response Behavior
We investigate how responses change over time—and how timing, coordination, and patterns across domains relate to brain function. That is the hypothesis we’re exploring.
Signal quality and reproducibility come first. Whether combined signals add useful information must be established through research.
Explore the research02 / Platform
Meet Neocognitron.
A multimodal neurocognitive signal capture and analysis platform.Investigational platform
Challenge the system.
Consistent tasks engage ocular, vestibular, reaction-time, cognitive, and motor responses.
NEOCOGNITRON Research architecture03 / Research
Traumatic brain injury is our first research application.
Understanding the human brain is our broader purpose.
We investigate whether patterns of Dynamic Response Behavior can help characterize neurological function beyond individual measurements. Signal quality and reproducibility are central to that work.
Research progression, not a clinical validation claim.
04 / Questions
The questions
behind the science.
Explore what we measure, why it matters, and what the evidence still needs to show.
What might a single neurological score miss?
A summary score can compress differences in timing, consistency, and how a response changes across repeated attempts. Cerebro is investigating whether studying those relationships adds useful information beyond individual measurements. That added value must be demonstrated, not assumed.
What can eye movements reveal beyond vision?
Eye-movement tasks let researchers examine how someone finds a target, follows movement, or responds to a changing instruction. Cerebro studies these responses alongside other functional domains. An eye-movement measurement alone does not establish a diagnosis.
What is Dynamic Response Behavior (DRB)—and why study responses over time?
Dynamic Response Behavior (DRB) describes how neurocognitive responses unfold over time—how they adapt to task demands, vary across repeated attempts, and relate across ocular, vestibular, reaction-time, cognitive, and motor domains. It guides our research; it is not a validated clinical score or diagnostic finding.
Why study five domains together?
Ocular, vestibular, reaction-time, cognitive, and motor tasks offer different ways to observe neurological function. Our hypothesis is that relationships between their responses may reveal information that separate measurements miss. More measurements do not automatically mean better assessment; their added value needs evidence.
Explore the five-domain diagramWhat evidence would show that Neocognitron works?
First, measurements must be reliable and reproducible. Then prospective studies must test performance in the intended population, against appropriate reference standards, and establish whether the combined signals add value over existing assessment. Our literature review explains the research rationale and its limits; it does not establish clinical validation of Neocognitron.
Explore the literature reviewCan Neocognitron be used in clinical care today?
Neocognitron is investigational. It is not cleared for diagnosis or independent treatment, disposition, or return-to-activity decisions. We welcome conversations about research collaboration; clinical use requires evidence for a defined intended use and the appropriate regulatory pathway.
Discuss research collaboration05 / Contact
The next discovery
may lie between the signals.
Research. Engineering. Scientific collaboration.
Exploring research collaboration, technology partnerships, or Cerebro’s work? We’d like to hear from you.
Email the Cerebro team Opens your email application. No form required.